The effects of levothyroxine replacement or suppressive therapy on health status, mood, and cognition

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 3, 2014, Pages 843-851

  Samuels, Mary H ^a   Kolobova, Irina ^a   Smeraglio, Anne ^a   Peters, Dawn ^a   Janowsky, Jeri S ^a   Schuff, Kathryn G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THYROID HORMONE;

ADULT; AFFECTIVE LABILITY SCALE; ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DECLARATIVE MEMORY; EXECUTIVE FUNCTION; FEMALE; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; LEARNING; MAJOR CLINICAL STUDY; MOOD; POSTPARTUM THYROIDITIS; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PSYCHOLOGIC TEST; SHORT FORM 36; SYMPTOM CHECKLIST 90; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROIDECTOMY; WORKING MEMORY;

ADULT; AFFECT; CASE-CONTROL STUDIES; COGNITION; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH STATUS; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; YOUNG ADULT;

EID: 84895785719     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3686     Document Type: Article

References (40)

1. Biondi B, Cooper DS. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid. 2010;20:135-146.
2. Samuels MH, Schuff KG, Carlson NE, Carello P, Janowsky JS. Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis. J Clin Endocrinol Metab. 2008;93:1730-1736. (Pubitemid 351656511)
3. Jaracz J, Kucharska A, Rajewska-Rager A, Lacka K. Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma. J Endocrinol Invest. 2012;35:760-765.
4. Tagay S, Herpertz S, Langkafel M, et al. Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. Eur J Endocrinol. 2005;153:755-763. (Pubitemid 43020225)
5. Eustatia-Rutten CF, Corssmit EP, Pereira AM, et al. Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol (Oxf). 2006;64:284-291.
6. Botella-Carretero JI, Galán JM, Caballero C, Sancho J, Escobar-Morreale HF. Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer. 2003;10:601-610. (Pubitemid 38094894)
7. Schuff KG, Samuels MH, Whybrow PC, Bauer M. Psychiatric and cognitive effects of hypothyroidism. In: Braverman LE, Cooper DS, eds. The Thyroid. 10th ed. Philadelphia, PA: Lippincott Williams, Wilkins; 2012:596-599.
8. Koromilas C, Liapi C, Schulpis KH, Kalafatakis K, Zarros A, Tsakiris S. Structural and functional alterations in the hippocampus due to hypothyroidism. Metab Brain Dis. 2010;25:339-354.
9. Spreen O, Strauss EA. ACompendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1998:90-102.
10. Spreen O, Strauss EA. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1998:612-616.
11. Spreen O, Strauss EA. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1998:644-646.
12. Wetzler S, Marlowe DB. The diagnosis and assessment of depression, mania, and psychosis by self-report. J Pers Assess. 1993;60:1-31.
13. Harvey PD, Greenberg BR, Serper MR. The affective lability scales: development, reliability, and validity. J Clin Psychol. 1989;45:786-793. (Pubitemid 19271464)
14. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. New York, NY: Oxford University Press; 1995:444-450.
15. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. New York, NY: Oxford University Press; 1995:363-364.
16. Spreen O, Strauss EA. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1998:208-212.
17. van Gorp WG, Altshuler L, Theberge DC, Mintz J. Declarative and procedural memory in bipolar disorder. Biol Psychiatry. 1999;46:525-531. (Pubitemid 29369080)
18. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, NY: Oxford University Press; 1998:1043.
19. Byrd DA, Touradji P, Tang MX, Manly JJ. Cancellation test performance in African American, Hispanic, and White elderly. J Int Neuropsychol Soc. 2004;10:401-411. (Pubitemid 38779812)
20. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. New York, NY: Oxford University Press; 1995:371-374.
21. Fellows LK. The role of orbitofrontal cortex in decision making: a component process account. Ann NY Acad Sci. 2007;1121:421-430.
22. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist. 1979;6:65-70.
23. Sait Gönen M, Kisakol G, Savas Cilli A, et al. Assessment of anxiety in subclinical thyroid disorders. Endocr J. 2004;51:311-315. (Pubitemid 38981070)
24. Schlote B, Nowotny B, Schaaf L, et al. Subclinical hyperthyroidism: physical and mental state of patients. Eur Arch Psychiatry Clin Neurosci. 1992;241:357-364.
25. Bommer M, Eversmann T, Pickardt R, Leonhardt A, Naber D. Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism. Klin Wochenschr. 1990;68:552-558. (Pubitemid 20190737)
26. Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006;37:133-139. (Pubitemid 41727903)
27. Biondi B, Palmieri EA, Fazio S, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab. 2000;85:4701-4705. (Pubitemid 32157655)
28. Roberts LM, Pattison H, Roalfe A, et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med. 2006;145:573-581. (Pubitemid 46780936)
29. de Jongh RT, Lips P, van Schoor NM, et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol. 2011;165:545-554.
30. Engum A, Bjøro T, Mykletun A, Dahl AA. An association between depression, anxiety and thyroid function - a clinical fact or an artefact? Acta Psychiatr Scand. 2002;106:27-34. (Pubitemid 34828145)
31. Almeida OP, Alfonso H, Flicker L, Hankey G, Chubb SA, Yeap BB. Thyroid hormones and depression: the Health in Men study. Am J Geriatr Psychiatry. 2011;19:763-770.
32. Panicker V, Evans J, Bjøro T, Asvold BO, Dayan CM, Bjerkeset O. A paradoxical difference in relationship between anxiety, depression and thyroid function in subjects on and not on T4: findings from the HUNT study. Clin Endocrinol (Oxf). 2009;71:574-580.
33. van de Ven AC, Netea-Maier RT, de Vegt F, et al. Is there a relationship between fatigue perception and the serum levels of thyrotropin and free thyroxine in euthyroid subjects? Thyroid. 2012;22:1236-1243.
34. Bianchi GP, Zaccheroni V, Solaroli E, et al. Health-related quality of life in patients with thyroid disorders. Qual Life Res. 2004;13:45-54.
35. Walsh JP, Ward LC, Burke V, et al. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab. 2006;91:2624-2630. (Pubitemid 44024628)
36. Wekking EM, Appelhof BC, Fliers E, et al. Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol. 2005;153:747-753. (Pubitemid 43020224)
37. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, DayanCM. Psychological well-being in patients on 'adequate' doses of l-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf). 2002;57:577-585. (Pubitemid 35316973)
38. Biondi B, Wartofsky L. Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab. 2012;97:2256-2271.
39. Kramer CK, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E. Treated hypothyroidism, cognitive function, and depressed mood in old age: the Rancho Bernardo Study. Eur J Endocrinol. 2009;161:917-921.
40. Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing l-thyroxine plus liothyronine with l-thyroxine alone. Ann Intern Med. 2005;142:412-424.